These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21975384)

  • 1. Thallium-201 scintigraphy is an effective diagnostic modality to distinguish malignant from benign soft-tissue tumors.
    Kawakami N; Kunisada T; Sato S; Morimoto Y; Tanaka M; Sasaki T; Sugihara S; Yanai H; Kanazawa S; Ozaki T
    Clin Nucl Med; 2011 Nov; 36(11):982-6. PubMed ID: 21975384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors.
    Yamamoto Y; Kawaguchi Y; Kawase Y; Maeda Y; Nishiyama Y
    Clin Nucl Med; 2011 Apr; 36(4):290-4. PubMed ID: 21368603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of Thallium-201 scintigraphy in differentiating malignant bone tumors from benign bone lesions.
    Inai R; Shinya T; Tada A; Sato S; Fujiwara T; Takeda K; Kunisada T; Yanai H; Ozaki T; Kanazawa S
    Ann Nucl Med; 2015 Oct; 29(8):674-81. PubMed ID: 26036991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thallium-201 chloride scintigraphy in soft tissue tumors.
    Otsuka H; Terazawa K; Morita N; Otomi Y; Takao S; Iwamoto S; Osaki K; Harada M; Nishitani H
    J Med Invest; 2009 Aug; 56(3-4):136-41. PubMed ID: 19763026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of TI-201 and three-phase bone scintigraphy for bone and soft-tissue tumors.
    Nishiyama Y; Yamamoto Y; Toyama Y; Satoh K; Ohkawa M; Tanabe M
    Clin Nucl Med; 2000 Mar; 25(3):200-5. PubMed ID: 10698418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of thallium-201 scintigraphy in bone and soft tissue tumors.
    Goto Y; Ihara K; Kawauchi S; Ohi R; Sasaki K; Kawai S
    J Orthop Sci; 2002; 7(3):304-12. PubMed ID: 12077654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of thallium-201 scintigraphy in bone and soft tissue tumors.
    Sato O; Kawai A; Ozaki T; Kunisada T; Danura T; Inoue H
    J Orthop Sci; 1998; 3(6):297-303. PubMed ID: 9811980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thallium-201 scintigraphy in bone and soft-tissue tumors: a comparison of dynamic, early and delayed scans.
    Sugawara Y; Kikuchi T; Kajihara M; Semba T; Ochi T; Fujii T; Mochizuki T; Sakayama K; Nakata S
    Ann Nucl Med; 2005 Sep; 19(6):461-8. PubMed ID: 16248382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic scintigraphy with thallium-201 chloride (Tl-201) for the diagnosis of tumors of the head and neck.
    Sato T; Indo H; Kawabata Y; Iwashita Y; Morita Y; Noikura T; Sugihara K; Mimura T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):228-35. PubMed ID: 11505272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
    Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Emoto K; Ashihara T; Hirasawa Y
    Anticancer Res; 2000; 20(5C):3967-70. PubMed ID: 11268485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quantitative assessment of 201Tl-SPECT in tumors of bone and soft tissue].
    Matsui R; Komori T; Nakata Y; Doi K; Tabuchi K; Saika Y; Utsunomiya K; Adachi I; Shimizu T; Sueyoshi K; Narabayashi I; Morishita S
    Kaku Igaku; 1999 Apr; 36(3):219-28. PubMed ID: 10358956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical usefulness of thallium-201 chloride in the diagnosis of tumor (II)--An evaluation in bone, soft tissue and mediastinal tumors].
    Tonami N; Itoh K; Yui N; Terui S; Torizuka K
    Kaku Igaku; 1994 Jan; 31(1):63-74. PubMed ID: 8309112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On clinical usefulness of Tl-201 scintigraphy for the management of malignant soft tissue tumors.
    Terui S; Terauchi T; Abe H; Fukuma H; Beppu Y; Chuman K; Yokoyama R
    Ann Nucl Med; 1994 Feb; 8(1):55-64. PubMed ID: 8204398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: comparison with Tl-201 imaging.
    Taki J; Higuchi T; Sumiya H; Tsuchiya H; Minato H; Tomita K; Tonami N
    J Orthop Res; 2008 Mar; 26(3):411-8. PubMed ID: 17960652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of soft tissue haemangioma by 201Tl scintigraphy.
    Higuchi T; Taki J; Nakajima K; Kinuya S; Nonomura A; Tsuchiya H; Bunko H; Namura M; Tonami N
    Nucl Med Commun; 2003 Mar; 24(3):327-30. PubMed ID: 12612475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
    Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
    Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy?
    Choong PF; Nizam I; Ngan SY; Schlict S; Powell G; Slavin J; Smith P; Toner G; Hicks R
    Eur J Surg Oncol; 2003 Dec; 29(10):908-15. PubMed ID: 14624787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Tc-99m pertechnetate with Tl-201 and Ga-67 scintigraphy of malignant soft-tissue tumors.
    Abe H; Terui S; Terauchi T; Muramatsu Y; Yokayama R; Ohtomo K; Beppu Y; Fukuma H
    Clin Nucl Med; 1997 Jan; 22(1):38-41. PubMed ID: 8993872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating benign and malignant bone and soft-tissue lesions with technetium-99m-MIBI scintigraphy.
    Taki J; Sumiya H; Tsuchiya H; Tomita K; Nonomura A; Tonami N
    J Nucl Med; 1997 Apr; 38(4):501-6. PubMed ID: 9098190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
    Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
    Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.